Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2019

Oct 28, 2019

31873_dirs_2019-10-28_4bea6e98-ca78-4357-aae2-1d674288e668.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-10-24

Reporting Person: BARTHELEMY NICOLAS (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-10-24 Director Stock Option (right to buy) $23.33 A 14573 Acquired 2029-10-23 Common Stock (14573) Direct

Footnotes

F1: 1/3rd of the shares subject to the option vest and become exercisable on October 24, 2020, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.